U.S. Interactive Media and Services Stock News

Sharplink (SBET) is drawing attention after another weak trading session, with the stock down 6.5% on the day and extending declines seen over the past week, month and past 3 months. See our latest analysis for Sharplink. At a latest share price of $4.97, Sharplink’s weak 1-day, 7-day and 30-day share price returns, along with a 1-year total shareholder return down 48.6% and 3-year total shareholder return down 85.17%, point to fading momentum as investors reassess growth prospects and risk...

In June 2026, iQIYI released the psychological thriller “None Shall Escape” on its domestic and international platforms, showcasing one of the first feature films produced using its NadouPro AI production system, which materially lifted visual effects shot efficiency and compressed complex post-production timelines. Since opening for commercial use in April, NadouPro has attracted more than 10,000 active creators and supported over 100 iQIYI original projects, signaling early traction for...

Thermo Fisher Scientific (TMO) is back in the spotlight after using the BIO International 2026 convention in San Diego to showcase AI driven research tools and integrated drug development workflows for pharma and biotech clients. See our latest analysis for Thermo Fisher Scientific. Thermo Fisher Scientific’s recent AI focus at BIO International comes after a mixed stretch for the stock, with the share price down 20.79% year to date but a 1 year total shareholder return of 16.49% signaling...

Western Midstream Partners, LP recently filed an omnibus shelf registration covering common and preferred units and Western Midstream Operating, LP debt securities, and its subsidiary priced a US$700,000,000 offering of 5.7% senior notes due 2036 to repay borrowings and fund capital expenditures. A second produced-water treatment pilot facility in Reeves County, Texas, built with Chevron, ConocoPhillips, Devon, and ExxonMobil, significantly expands Western Midstream’s reclaimed freshwater...

Byline Bancorp’s first-quarter 2026 results, reported earlier this year, showed earnings per share of US$0.83, ahead of analyst expectations of US$0.75 despite a slight revenue shortfall. This earnings outperformance, coming alongside only a modest revenue miss, points to improved efficiency and cost control as key drivers of profitability. With earnings beating expectations, we’ll explore how this profit strength influences Byline Bancorp’s existing investment narrative and risk-return...

Keel Infrastructure (KEEL) is back in focus after investors reacted to new government backed project wins and a multi year contracts pipeline that has pushed trading volumes higher and highlighted its AI infrastructure ambitions. See our latest analysis for Keel Infrastructure. Keel Infrastructure’s share price has been on a strong run, with a 30 day share price return of 30.77% and a 90 day share price return of 184.62%. Its 1 year total shareholder return is about 7x, reflecting rising...

Earlier in June 2026, Crinetics Pharmaceuticals presented new clinical data at ENDO 2026, including Phase 2 results for investigational atumelnant in congenital adrenal hyperplasia and long-term open-label extension findings for once-daily oral PALSONIFY in acromegaly. The combination of biomarker reductions and glucocorticoid dose lowering with atumelnant, alongside multi-year PALSONIFY efficacy and safety data, underscores Crinetics’ potential breadth in endocrine care. We’ll now examine...

Universal Health Services recently reported quarterly revenue of US$4.50 billion, an increase of 9.6% year on year, and exceeded analyst expectations on both revenue and earnings. In parallel, the company was recognized by Newsweek and Plant A Insights Group as one of America’s Greatest Workplaces in Health Care 2026, underscoring how its workplace culture may support ongoing operational execution. With this strong earnings beat and workplace recognition in mind, we’ll now explore how these...

Quantum computing has moved from theory to policy priority, and the latest US executive orders on quantum adoption and quantum-resistant encryption put that shift in sharp focus. With plans for a national lab-based quantum computer by 2028, plus federal grants and funding streams tied to the CHIPS and Science Act, stocks exposed to this news, such as D-Wave Quantum, are firmly on investors’ radar. This article walks through 3 stocks from our Quantum Computing Stocks With US Government Growth...

Recent Performance Snapshot for USA Compression Partners USA Compression Partners (USAC) has drawn fresh attention after a recent move in its unit price, with the stock up 2.7% over the past day and 2.0% over the past week. Despite that short term uptick, units are down about 9.7% over the past month and 7.0% over the past 3 months, which may prompt investors to reassess how current pricing lines up with the partnership’s fundamentals. See our latest analysis for USA Compression Partners. Set...

AI related spending by the Magnificent Seven is projected to reach US$668b in 2026, while higher for longer interest rates keep pressure on tech valuations and funding costs. That mix of heavy capital expenditure and tighter money puts a spotlight on one thing: free cash flow. Investors are asking which stocks can keep generating cash even as they invest in AI infrastructure, and which might struggle if returns are slower than hoped. This article looks at 3 stocks from a High Free Cash Flow...

On Holding (ONON) is in focus after its shift from a pure running label to a premium lifestyle brand, supported by new cushioning technologies and recent quarterly results that showed higher revenue and wider margins. See our latest analysis for On Holding. Despite the strong Q1 revenue and margin figures, On Holding’s share price has been under pressure, with the 30 day share price return down 11.73% and the year to date share price return down 25.15%. Over a longer horizon, the 3 year total...

Veeva Systems recently reported fiscal Q1 2027 results with double-digit revenue and subscription growth, beating its own guidance and lifting its full-year outlook. At the same time, Veeva accelerated its push into AI with new agent-based platform plans and the acquisitions of Ostro and Copli, deepening automation across life sciences workflows. We’ll now explore how Veeva’s stronger outlook and push into AI-powered agentic solutions could reshape the company’s broader investment...

In June 2026, ZenaTech, Inc. unveiled Zoo Office, an AI-powered unified productivity platform intended to become the core foundation and brand for its Enterprise SaaS ecosystem, initially rolling out via a private beta targeting small and medium-sized businesses. The Zoo Office roadmap is distinctive because it aims to combine agentic AI, core productivity tools, and industry-specific applications into a single connected platform that reduces subscription sprawl and fragmented workflows. We...

In recent days, Philip Morris International announced new regional leadership appointments effective August 1, 2026, while also affirming a quarterly dividend of US$1.4700 per share payable on July 20, 2026. Together with recent regulatory signals in the EU and the U.S. that appear to reduce perceived policy risk, these moves highlight how governance, cash returns, and the regulatory backdrop are all shaping Philip Morris International’s smoke-free transition. We’ll now examine how the...

UDR (UDR) is back on investors’ radar after recent trading put the stock near its latest close of US$38.28. This has prompted fresh interest in how this multifamily REIT’s returns compare with its fundamentals. See our latest analysis for UDR. Recent moves in UDR’s share price, including a 1.43% one-day share price return and a 12.82% 90-day share price return, contrast with a 1-year total shareholder return that declined 2.12%. This suggests improving short-term momentum following a weaker...

DoorDash (DASH) is in focus after announcing a partnership with Dollar Tree that brings on demand delivery to more than 9,000 stores across 48 states and expands its presence in value focused retail. See our latest analysis for DoorDash. The Dollar Tree partnership lands as DoorDash stock shows mixed momentum, with a 30 day share price return of 7.03% and a 90 day gain of 12.16%. However, the stock has a year to date decline of 21.96% and a 1 year total shareholder return down 27.37%, while...

Penny stocks usually live or die on one thing, cash. In a world where growth signals are mixed across Europe, the UK, North America and Asia, and where energy prices, inflation and policy decisions can shift sentiment quickly, having a solid balance sheet matters even more for smaller companies. The Elite Penny Stocks screener focuses on stocks that still trade at penny levels but have the financial strength to keep funding their plans. In this article, you will see 3 of the best stocks from...

United States Antimony (UAMY) is back on investors’ radar after recent trading highlighted sharp share price moves, alongside mixed return figures that include gains year to date but declines over the past month and over the past 3 months. See our latest analysis for United States Antimony. Recent trading in United States Antimony has been choppy, with a 1-day share price return of down 10.13% to $7.01 and a 30-day share price return of down 16.75%. At the same time, the year to date share...

In recent days, Arm Holdings has been caught in a global pullback in high-growth semiconductor and AI names, as investors reassessed richly valued technology stocks amid concerns about higher interest rates and sector rotation. At the same time, Arm’s record fiscal 2026 results, deepening AI data center traction, and entry into custom silicon have sharpened the debate over how much growth is already reflected in its valuation and business model. Beyond the market volatility, Arm’s expanded...

The Rosen Law Firm has launched an investigation into potential fiduciary duty breaches by directors and officers of Manhattan Associates (MANH). This development is prompting some investors to reassess how governance risk factors into their view of the stock. See our latest analysis for Manhattan Associates. Manhattan Associates' 1-day share price return of 1.09% contrasts with a weaker trend, with the 30-day share price return down 6.10% and the year to date share price return down 22.18%...

Aramark (ARMK) has drawn investor attention after recent share price moves, with the stock last closing at $53.76. The company’s performance and current valuation are in focus as investors reassess its long-term prospects. See our latest analysis for Aramark. Recent share price moves for Aramark sit against a longer run of strong momentum, with a 30 day share price return of 4.88% and a year to date share price return of 46.97%, alongside a 5 year total shareholder return of 114.02%. If...

Recent Performance Snapshot for Regions Financial Stock Regions Financial (RF) shares recently closed at $29.29, with recent returns of 1 day at 1.88%, past week at 1%, past month at 5.25%, and past 3 months at 13.70%. Over longer horizons, the stock shows a 6.28% year to date total return, 33.14% over the past year, 9.12x over 3 years, and 7.93x over 5 years. This provides investors with a view of how the bank’s shares have traded across different market periods. See our latest analysis for...

Illumina, Inc. has expanded its Board of Directors from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, as an independent director effective June 16, 2026. By adding a senior R&D leader with deep experience in drug discovery, clinical development, and precision medicine, Illumina is strengthening board-level expertise closely aligned with its genomics and multiomics...